O'Shaughnessy Asset Management, LLC Voyager Therapeutics, Inc. Transaction History

O'Shaughnessy Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$7.42 - $10.54 $33,367 - $47,398	-4,497 Reduced 20.58%	17,352 $137,000
Q1 2024 May 13, 2024	SELL	$7.15 - $10.84 $43,014 - $65,213	-6,016 Reduced 21.59%	21,849 $203,000
Q4 2023 Feb 09, 2024	SELL	$6.28 - $8.81 $149,621 - $209,898	-23,825 Reduced 46.09%	27,865 $235,000
Q3 2023 Nov 13, 2023	BUY	$7.55 - $11.25 $221,449 - $329,973	29,331 Added 131.18%	51,690 $400,000
Q2 2023 Aug 11, 2023	BUY	$6.94 - $13.99 $155,171 - $312,802	22,359 New	22,359 $256,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $223M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.